8 documenten
-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 1694786673 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5PDF | 471,66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 1694786544 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5DOCX | 30,30 kB
-
10-2021 Guidance document VOV art 39b gm-cells LV-RV 1634241579 10-2021 Guidance document VOV art 39b gm-cells LV-RVPDF | 238,45 kB
-
2020-07-23 Guidance document gm-cells - Netherlands _V1.1 1634241329 2020-07-23 Guidance document gm-cells - Netherlands _V1.1PDF | 286,57 kB
-
Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels 1634241119 Gestandaardiseerde MRB VOV gm cellen zonder viruspartikelsPDF | 455,40 kB
-
Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes 1634239724 Gestandaardiseerde MRB VOV gm cellen LV met SIN deeltjes PDF | 529,10 kB
-
10-2021 Guidance document VOV art 39c gm-cells LV-SIN 1634239325 10-2021 Guidance document VOV art 39c gm-cells LV-SINPDF | 237,28 kB